\-\ Texto\\:\\ \ \(0\)\
\-\ multiple\\ lumps\\ near\\ the\\ articulations\\ involving\\ the\\ knees\\,\\ wrists\\,\\ and\\ shoulders\\.\ \(0\)\
\-\ routine\\ follow\\ up\\ unless\\ they\\ become\\ symptomatic\\ or\\ continue\\ to\\ grow\\ past\\ skeletal\\ maturity\\,\\ or\\ start\\ to\\ grow\\ again\\ after\\ a\\ period\\ of\\ quiescence\\,\\ which\\ may\\ indicate\\ malignant\\ transformation\\ and\\ warrant\\ additional\\ evaluation\\ leading\\ to\\ surgical\\ intervention\\.\ \(0\)\
\-\ multiple\\ bony\\ outgrowths\\ with\\ sessile\\ or\\ partially\\ pedunculated\\ morphology\\.\\ on\\ mri\\ these\\ lesions\\ follow\\ normal\\ marrow\\ signal\\,\\ indicating\\ they\\ have\\ a\\ fatty\\ content\\ similar\\ to\\ bone\\ marrow\\.\ \(0\)\
\-\ multiple\\ hereditary\\ exostoses\ \(0\)\
\-\ enchondroma\ \(73\)\
\-\ multiple\\ osteochondromas\ \(4\)\
\-\ ollier\\'s\\ disease\ \(0\)\
\-\ maffucci\\ syndrome\ \(0\)\
\-\ fibrous\\ dysplasia\ \(50\)\
\-\ eosinophilic\\ granuloma\ \(17\)\
\-\ 8\\ year\\ old\\ with\\ multiple\\ joint\\ lumps\\.\ \(1\)\
\-\ diaphyseal\\ aclasis\\ \\(hereditary\\ exostoses\\ or\\ osteochondromatosis\\)\\.\\ autosomal\\ dominant\\ transmission\\.\\ presents\\ as\\ multiple\\ palpable\\ masses\\ near\\ joint\\ articulations\\ on\\ physical\\ exam\\.\\ multiple\\ osteochondromas\\ that\\ enlarge\\ and\\ \\ grow\\ until\\ skeletal\\ maturity\\.\\ these\\ lesions\\ virtually\\ always\\ involve\\ the\\ knees\\.\\ 20\\%\\ of\\ these\\ lesions\\ may\\ undergo\\ malignant\\ transformation\\ and\\ \\ likely\\ involve\\ the\\ axial\\ portions\\ of\\ the\\ skeleton\\.\ \(0\)\
\-\ http\\:\\/\\/www\\.diseasesdatabase\\.com\\/ddb29635\\.htm\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ lumps\\:\\ 0\\.10250602818565696\ \(0\)\
\-\ grow\\:\\ 0\\.09693177708043632\ \(0\)\
\-\ articulations\\:\\ 0\\.0816716157527726\ \(0\)\
\-\ multiple\\:\\ 0\\.07324791874624932\ \(0\)\
\-\ osteochondromas\\:\\ 0\\.0718193150505958\ \(0\)\
\-\ maturity\\:\\ 0\\.07101707235888707\ \(0\)\
\-\ exostoses\\:\\ 0\\.06956168697570095\ \(0\)\
\-\ knees\\:\\ 0\\.057736870026237674\ \(0\)\
\-\ hereditary\\:\\ 0\\.05701738858765525\ \(0\)\
\-\ transformation\\:\\ 0\\.05633984314435322\ \(0\)\
\-\ quiescence\\:\\ 0\\.05125301409282848\ \(0\)\
\-\ outgrowths\\:\\ 0\\.05125301409282848\ \(0\)\
\-\ aclasis\\:\\ 0\\.05125301409282848\ \(0\)\
\-\ \\/\\/www\\.diseasesdatabase\\.com\\/ddb29635\\.htm\\:\\ 0\\.05125301409282848\ \(0\)\
\-\ skeletal\\:\\ 0\\.04907440202130126\ \(0\)\
\-\ involve\\:\\ 0\\.04683751954865643\ \(0\)\
\-\ marrow\\:\\ 0\\.04371247230951384\ \(0\)\
\-\ near\\:\\ 0\\.0429944722273226\ \(0\)\
\-\ maffucci\\:\\ 0\\.04189581692751394\ \(0\)\
\-\ lesions\\:\\ 0\\.03989931115716188\ \(0\)\
\-\ these\\:\\ 0\\.03878798881321814\ \(0\)\
\-\ warrant\\:\\ 0\\.03847845259668766\ \(0\)\
\-\ ollier\\:\\ 0\\.036340517828517216\ \(0\)\
\-\ malignant\\:\\ 0\\.035914775306736056\ \(0\)\
\-\ diaphyseal\\:\\ 0\\.0359096575252979\ \(0\)\
\-\ osteochondromatosis\\:\\ 0\\.0359096575252979\ \(0\)\
\-\ enlarge\\:\\ 0\\.0359096575252979\ \(0\)\
\-\ they\\:\\ 0\\.03580169914520123\ \(0\)\
\-\ sessile\\:\\ 0\\.03513331221934138\ \(0\)\
\-\ start\\:\\ 0\\.03444852712831589\ \(0\)\
\-\ transmission\\:\\ 0\\.03413418281860499\ \(0\)\
\-\ content\\:\\ 0\\.03355230224559927\ \(0\)\
\-\ wrists\\:\\ 0\\.03231059236014544\ \(0\)\
\-\ joint\\:\\ 0\\.032132898314442805\ \(0\)\
\-\ follow\\:\\ 0\\.03157208688309807\ \(0\)\
\-\ pedunculated\\:\\ 0\\.03147861071107176\ \(0\)\
\-\ virtually\\:\\ 0\\.03147861071107176\ \(0\)\
\-\ skeleton\\:\\ 0\\.030418601659944117\ \(0\)\
\-\ shoulders\\:\\ 0\\.030104257350233213\ \(0\)\
\-\ morphology\\:\\ 0\\.029662478821291804\ \(0\)\
\-\ enchondroma\\:\\ 0\\.029522376777227497\ \(0\)\
\-\ autosomal\\:\\ 0\\.028746031471270975\ \(0\)\
\-\ indicate\\:\\ 0\\.02816992157217661\ \(0\)\
\-\ unless\\:\\ 0\\.02689455629034926\ \(0\)\
\-\ continue\\:\\ 0\\.02680712677078798\ \(0\)\
\-\ eosinophilic\\:\\ 0\\.02663611581028627\ \(0\)\
\-\ portions\\:\\ 0\\.02584924750871789\ \(0\)\
\-\ fatty\\:\\ 0\\.025776115054026837\ \(0\)\
\-\ indicating\\:\\ 0\\.02563255335292003\ \(0\)\
\-\ always\\:\\ 0\\.025562080326569186\ \(0\)\
\-\ dominant\\:\\ 0\\.025355646091354593\ \(0\)\
\-\ undergo\\:\\ 0\\.025221986101676114\ \(0\)\
\-\ granuloma\\:\\ 0\\.02442091806468162\ \(0\)\
\-\ again\\:\\ 0\\.02387202455031491\ \(0\)\
\-\ leading\\:\\ 0\\.023768201193338126\ \(0\)\
\-\ become\\:\\ 0\\.02366619939304214\ \(0\)\
\-\ or\\:\\ 0\\.02329122672008622\ \(0\)\
\-\ period\\:\\ 0\\.023228121269543378\ \(0\)\
\-\ partially\\:\\ 0\\.022733974683302724\ \(0\)\
\-\ intervention\\:\\ 0\\.022121413545757224\ \(0\)\
\-\ until\\:\\ 0\\.021819322040346114\ \(0\)\
\-\ may\\:\\ 0\\.021794515917420043\ \(0\)\
\-\ fibrous\\:\\ 0\\.02008271080382019\ \(0\)\
\-\ routine\\:\\ 0\\.0199212017101744\ \(0\)\
\-\ additional\\:\\ 0\\.0199212017101744\ \(0\)\
\-\ bony\\:\\ 0\\.019868347223539216\ \(0\)\
\-\ symptomatic\\:\\ 0\\.01973827572496635\ \(0\)\
\-\ dysplasia\\:\\ 0\\.019611050659562236\ \(0\)\
\-\ similar\\:\\ 0\\.01948655011012144\ \(0\)\
\-\ http\\:\\ 0\\.018812724406862068\ \(0\)\
\-\ 8\\:\\ 0\\.018576264873542723\ \(0\)\
\-\ 20\\:\\ 0\\.017863460675331486\ \(0\)\
\-\ palpable\\:\\ 0\\.017608261875580178\ \(0\)\
\-\ involving\\:\\ 0\\.017432600372112174\ \(0\)\
\-\ masses\\:\\ 0\\.01679414184881446\ \(0\)\
\-\ past\\:\\ 0\\.015786043441549037\ \(0\)\
\-\ evaluation\\:\\ 0\\.014431620905969812\ \(0\)\
\-\ syndrome\\:\\ 0\\.01420875916706187\ \(0\)\
\-\ axial\\:\\ 0\\.014179020209696927\ \(0\)\
\-\ likely\\:\\ 0\\.014013313755439863\ \(0\)\
\-\ up\\:\\ 0\\.013359576459617578\ \(0\)\
\-\ signal\\:\\ 0\\.013099269362051039\ \(0\)\
\-\ bone\\:\\ 0\\.012345550473603894\ \(0\)\
\-\ physical\\:\\ 0\\.012188984125472315\ \(0\)\
\-\ \\%\\:\\ 0\\.011589075775267486\ \(0\)\
\-\ mri\\:\\ 0\\.011414394505317556\ \(0\)\
\-\ \\'s\\:\\ 0\\.010953759409110727\ \(0\)\
\-\ exam\\:\\ 0\\.010914150813660106\ \(0\)\
\-\ have\\:\\ 0\\.010758360920727277\ \(0\)\
\-\ surgical\\:\\ 0\\.010443149827043335\ \(0\)\
\-\ after\\:\\ 0\\.010279076759355828\ \(0\)\
\-\ presents\\:\\ 0\\.01014909474132515\ \(0\)\
\-\ to\\:\\ 0\\.009931816475418284\ \(0\)\
\-\ which\\:\\ 0\\.009274096437456678\ \(0\)\
\-\ that\\:\\ 0\\.008581283305574554\ \(0\)\
\-\ on\\:\\ 0\\.008417337353086373\ \(0\)\
\-\ disease\\:\\ 0\\.008120567100091304\ \(0\)\
\-\ \\,\\:\\ 0\\.007869478648758354\ \(0\)\
\-\ normal\\:\\ 0\\.007788444503483145\ \(0\)\
\-\ as\\:\\ 0\\.0075149854993844635\ \(0\)\
\-\ \\:\\:\\ 0\\.006571365209248052\ \(0\)\
\-\ year\\:\\ 0\\.005558751565540202\ \(0\)\
\-\ old\\:\\ 0\\.005086829051524736\ \(0\)\
\-\ a\\:\\ 0\\.004611625602541875\ \(0\)\
\-\ \\(\\:\\ 0\\.00419977747816198\ \(0\)\
\-\ and\\:\\ 0\\.0041862559472608946\ \(0\)\
\-\ \\)\\:\\ 0\\.0041484749541471225\ \(0\)\
\-\ the\\:\\ 0\\.004018874555337959\ \(0\)\
\-\ \\.\\:\\ 0\\.0022703191690163316\ \(0\)\
\-\ of\\:\\ 0\\.0020320430371742167\ \(0\)\
\-\ with\\:\\ 0\\.0013605136754638342\ \(0\)\
